nanotech investing Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors
nanotech investing Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
nanotech investing ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox
nanotech investing Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief Regulatory Officer
nanotech investing Nuvation Bio Announces FDA Partial Clinical Hold for Phase 1 Study of NUV-422 in Solid Tumors
SAGA Metals Engages Paul McGuigan as its Qualified Person to Oversee Advancement of the Radar Ti-V-Fe Project in Labrador & Provides Corporate Update
CHARBONE Hydrogen Executed a USD 50MM Financing to Accelerate its Hydrogen's North American Expansion Facilitated by US Capital Global
Charbone Hydrogene a execute un financement de 50 millions USD pour accelerer son expansion en hydrogene en Amerique du Nord, facilite par US Capital Global
Radiopharm Theranostics Doses First Patient in Phase 1 'HEAT' Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
